Search Results - "Verhoeven, Rob H A"

Synchronous peritoneal metastases of gastric cancer origin: incidence, treatment and survival of a nationwide Dutch cohort by Koemans, Willem J., Lurvink, Robin J., Grootscholten, Cecile, Verhoeven, Rob H. A., de Hingh, Ignace H., van Sandick, Johanna W.

“…Introduction The peritoneum is a predilection site for gastric cancer metastases. Current standard treatment for gastric cancer patients with synchronous…”
Get full text

The Impact of Primary Tumor Location in Synchronous Metastatic Colorectal Cancer: Differences in Metastatic Sites and Survival by Brouwer, Nelleke P. M., van der Kruijssen, Dave E. W., Hugen, Niek, de Hingh, Ignace H. J. T., Nagtegaal, Iris D., Verhoeven, Rob H. A., Koopman, Miriam, de Wilt, Johannes H. W.

“…Purpose We explored differences in survival between primary tumor locations, hereby focusing on the role of metastatic sites in synchronous metastatic…”
Get full text

Factors influencing the quality and functioning of oncological multidisciplinary team meetings: results of a systematic review by Walraven, Janneke E. W, van der Hel, Olga L, van der Hoeven, J. J. M, Lemmens, Valery E. P. P, Verhoeven, Rob H. A, Desar, Ingrid M. E

“…Abstract Background Discussing patients with cancer in a multidisciplinary team meeting (MDTM) is customary in cancer care worldwide and requires a significant…”
Get full text

The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer by Doeve, Benthe H., Bakx, Jeanne A. C., Siersema, Peter D., Rosman, Camiel, van Grieken, Nicole C. T., van Berge Henegouwen, Mark I., van Sandick, Johanna W., Verheij, Marcel, Bijlsma, Maarten F., Verhoeven, Rob H. A., van Laarhoven, Hanneke W. M.

“…Background The COVID-19 pandemic has affected the entire global healthcare system, including oncological care. This study investigated the effects of the…”
Get full text

Sex differences in tumor characteristics, treatment, and outcomes of gastric and esophageal cancer surgery: nationwide cohort data from the Dutch Upper GI Cancer Audit by Kalff, Marianne C., Wagner, Anna D., Verhoeven, Rob H. A., Lemmens, Valery E. P. P., van Laarhoven, Hanneke W. M., Gisbertz, Suzanne S., van Berge Henegouwen, Mark I.

“…Background Sex differences in clinicopathological characteristics, treatment, and postoperative outcomes of gastric and esophageal cancer are largely…”
Get full text

Increased assessment of HER2 in metastatic gastroesophageal cancer patients: a nationwide population-based cohort study by Dijksterhuis, Willemieke P. M., Verhoeven, Rob H. A., Meijer, Sybren L., Slingerland, Marije, Haj Mohammad, Nadia, de Vos-Geelen, Judith, Beerepoot, Laurens V., van Voorthuizen, Theo, Creemers, Geert-Jan, van Oijen, Martijn G. H., van Laarhoven, Hanneke W. M.

“…Background Addition of trastuzumab to first-line palliative chemotherapy in gastroesophageal cancer patients with HER2 overexpression has shown to improve…”
Get full text

Effects of age and comorbidity on treatment and survival of patients with muscle‐invasive bladder cancer by Goossens‐Laan, Catharina A., Leliveld, Anna M., Verhoeven, Rob H.A., Kil, Paul J.M., Bock, Geertruida H., Hulshof, Maarten C.C.M., Jong, Igle J., Coebergh, Jan Willem W.

“…Our study assessed whether rising age, socioeconomic status (SES) and the presence of serious comorbidity affected treatment choice and survival in a…”
Get full text

Preparing tomorrow’s medical specialists for participating in oncological multidisciplinary team meetings: perceived barriers, facilitators and training needs by Walraven, Janneke E. W, van der Meulen, Renske, van der Hoeven, Jacobus J. M, Lemmens, Valery E. P. P, Verhoeven, Rob H. A, Hesselink, Gijs, Desar, Ingrid M. E

“…Abstract Introduction The optimal treatment plan for patients with cancer is discussed in multidisciplinary team meetings (MDTMs). Effective meetings require…”
Get full text

A conditional model predicting the 10-year annual extra mortality risk compared to the general population: a large population-based study in Dutch breast cancer patients by van Maaren, Marissa C, Kneepkens, Robert F, Verbaan, Joke, Huijgens, Peter C, Lemmens, Valery E P P, Verhoeven, Rob H A, Siesling, Sabine

“…Many cancer survivors are facing difficulties in getting a life insurance; raised premiums and declinatures are common. We generated a prediction model…”
Get full text

Comparing treatment and outcomes in advanced esophageal, gastroesophageal junction, and gastric adenocarcinomas: a population-based study by Pape, Marieke, Vissers, Pauline A. J., Dijksterhuis, Willemieke P. M., Bertwistle, David, McDonald, Laura, Mostert, Bianca, Derks, Sarah, Oving, Irma M., Verhoeven, Rob H. A., van Laarhoven, Hanneke W. M.

“…Background: Treatment of advanced or metastatic esophageal adenocarcinoma (EAC) follows the guidelines for gastroesophageal junction adenocarcinoma (GEJC) and…”
Get full text

Adrenocortical carcinoma: A population-based study on incidence and survival in the Netherlands since 1993 by Kerkhofs, Thomas M.A, Verhoeven, Rob H.A, Van der Zwan, Jan Maarten, Dieleman, Jeanne, Kerstens, Michiel N, Links, Thera P, Van de Poll-Franse, Lonneke V, Haak, Harm R

“…Abstract Background The reported annual incidence of adrenocortical carcinoma (ACC) is 0.5–2.0 cases per million individuals. Updated population-based studies…”
Get full text

An overview of 25 years of incidence, treatment and outcome of colorectal cancer patients by Brouwer, Nelleke P.M., Bos, Amanda C.R.K., Lemmens, Valery E.P.P., Tanis, Pieter J., Hugen, Niek, Nagtegaal, Iris D., Wilt, Johannes H.W., Verhoeven, Rob H.A.

“…Regarding the continuous changes in the diagnostic process and treatment of colorectal cancer (CRC), it is important to evaluate long‐term trends which are…”
Get full text

Gender Differences in Treatment Allocation and Survival of Advanced Gastroesophageal Cancer: A Population-Based Study by Dijksterhuis, Willemieke P M, Kalff, Marianne C, Wagner, Anna D, Verhoeven, Rob H A, Lemmens, Valery E P P, van Oijen, Martijn G H, Gisbertz, Suzanne S, van Berge Henegouwen, Mark I, van Laarhoven, Hanneke W M

“…Biological sex and gender have been reported to affect incidence and overall survival (OS) of curatively treated gastroesophageal cancer. The aim of this study…”
Get full text

Endoscopic therapy replaces surgery for clinical T1 oesophageal cancer in the Netherlands: a nationwide population-based study by Noordzij, Irma C., Hazen, Marije L., Nieuwenhuijzen, Grard A. P., Verhoeven, Rob H. A., Schoon, Erik J.

“…Background Endoscopic resection for early oesophageal cancer was introduced around 2000 in the Netherlands. The scientific question was how the treatment and…”
Get full text

Evaluation of the Implementation of FDG-PET/CT and Staging Laparoscopy for Gastric Cancer in The Netherlands by Gertsen, Emma C., Borggreve, Alicia S., Brenkman, Hylke J. F., Verhoeven, Rob H. A., Vegt, Erik, van Hillegersberg, Richard, Siersema, Peter D., Ruurda, Jelle P.

“…Background The role of 18 F-fluorodeoxyglucose positron emission tomography with computed tomography (FDG-PET/CT) and staging laparoscopy (SL) has increased in…”
Get full text

Gastrointestinal Symptoms After Resection of Esophagogastric Cancer: A Longitudinal Study on Their Incidence and Impact on Patient-Reported Outcomes by van Erning, Felice N., Nieuwenhuijzen, Grard A. P., van Laarhoven, Hanneke W. M., Rosman, Camiel, Gisbertz, Suzanne S., Heisterkamp, Joos, Lagarde, Sjoerd M., Slingerland, Marije, van den Berg, Jan-Willem, Kouwenhoven, Ewout A., Verhoeven, Rob H. A., Vissers, Pauline A. J.

“…Background This study assesses the incidence of gastrointestinal symptoms in the first year after resection of esophageal or gastric cancer and its association…”
Get full text

Multimodal Therapy Versus Primary Surgery for Gastric and Gastroesophageal Junction Diffuse Type Carcinoma, with a Focus on Signet Ring Cell Carcinoma: A Nationwide Study by Gertsen, Emma C., van der Veen, Arjen, Brenkman, Hylke J. F., Brosens, Lodewijk A. A., van der Post, Rachel S., Verhoeven, Rob H. A., Luijten, Josianne C. H. B. M., Vissers, Pauline A. J., Vegt, Erik, van Hillegersberg, Richard, Siersema, Peter D., Ruurda, Jelle P.

“…Background Diffuse type adenocarcinoma and, more specifically, signet ring cell carcinoma (SRCC) of the stomach and gastroesophageal junction (GEJ) have a poor…”
Get full text

ASO Visual Abstract: Multimodal Therapy Versus Primary Surgery for Gastric and Gastroesophageal Junction Diffuse Type Carcinoma, with a Focus on Signet Ring Cell Carcinoma: A Nationwide Study by Gertsen, Emma C., van der Veen, Arjen, Brenkman, Hylke J. F., Brosens, Lodewijk A. A., van der Post, Rachel S., Verhoeven, Rob H. A., Luijten, Josianne C. H. B. M., Vissers, Pauline A. J., Vegt, Erik, van Hillegersberg, Richard, Siersema, Peter D., Ruurda, Jelle P.

Get full text

A population-based comparison of patients with metastatic esophagogastric carcinoma between Japan and the Netherlands by Pape, Marieke, Vissers, Pauline A. J., Kato, Ken, Haj Mohammad, Nadia, Klarenbeek, Bastiaan, van Laarhoven, Hanneke W. M., Matsuda, Tomohiro, Verhoeven, Rob H. A.

“…Purpose Differences exist between Asian and Western patients with esophagogastric cancer, for example in terms of histological subtype and treatment…”
Get full text

Long-term health-related quality of life in patients with advanced esophagogastric cancer receiving first-line systemic therapy by Pape, Marieke, Vissers, Pauline A. J., Slingerland, Marije, Haj Mohammad, Nadia, van Rossum, Peter S. N., Verhoeven, Rob H. A., van Laarhoven, Hanneke W. M.

“…Purpose To investigate the effect of systemic therapy on health-related quality of life (HRQoL) in patients with advanced esophagogastric cancer in daily…”
Get full text